Presentation Information
[P2-01]Multi-laboratory study of LC/MS method development for the quantification of 3003pep in plasma
*Rika Ishikawa1, Kosuke Saito1, Mikio Shirasaki2, Koichi Shiga2, Naoko Arashida3, Kazuki Yamamoto3, Masayoshi Mizuochi4, Aki Koyama4, Kayo Iwasaki5, Suguru Fukuda5, Yuki Kishino6, Hitomi Shimoda6, Hitoshi Uchiyama7, Rikako Une7, Ryo Yamato8, Ryoya Goda9, Takashi Misawa1, Yosuke Demizu1, Yoshiro Saito1, Ruri Kikura-Hanajiri 1 (1. National Institute of Health Sciences, 2. Axcelead Drug Discovery Partners, Inc., 3. Ajinomoto. Co., Inc., 4. CMIC Pharma Science Co., Ltd., 5. Shin Nippon Biomedical Laboratories, Ltd., 6. Daiichi Sankyo Co., Ltd., 7. Towa Pharmaceutical Co., Ltd., 8. Mediford Corporation, 9. Future Peak)
Keywords:
Cyclic peptides,Liquid chromatography/mass spectrometry,3003pep
Password required to view
Log in
or